Product Wiki · Recalls · EU Safety Gate (RAPEX)

YALLIK DELIKLI BOLEROLU ELBISE — recall A12/00333/24

EU Safety Gate (RAPEX) · Hungary · 2024-02-16 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/00333/24
Date of alert
2024-02-16
Country / jurisdiction
Hungary
Risk level
Serious risk
Risk type
Choking
Brand
BULSEN BABY
Product category
Clothing, textiles and fashion items
Product type
Children's dress
Barcode (EAN/GTIN)
8680445164172
Reported risk: A ruhadarab kis dekorációs elemei (strasszok) könnyen leválhatnak. Egy kisgyermek a szájába veheti és megfulladhat. A termék nem felel meg az Általános Termékbiztonsági követelményeknek.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Withdrawal of the product from the market
Date of entry into force
11/12/2023
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): YALLIK DELIKLI BOLEROLU ELBISE

Risk Description (original English): The small decorative elements (rhinestones) of the garment can easily be detached. A small child may put them in the mouth and choke.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10011908

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.